Pressemelding —
Zooca strengthens science platform with appointment of Lisa Myrseth Hemmingsen
JUNE 2026: Zooca (Calanus AS) has appointed Lisa Myrseth Hemmingsen as Head of Science, Human Health and Nutrition, strengthening its scientific platform and advancing documentation for Zooca® Calanus® Oil, the company’s distinctive marine oil for human health applications.
Hemmingsen joins from UiT The Arctic University of Norway, where she was an Associate Professor with interdisciplinary research experience spanning lipids, bioactive compounds and pharmaceutical technology.
In the new role, she will help connect research, product development and commercial priorities, with responsibility for scientific documentation, external collaborations and science-based communication with customers and partners.
Her responsibilities will include strengthening the scientific documentation of Zooca Calanus Oil and other marine ingredients for human health and nutrition, as well as initiating and coordinating external research projects with academic and industry partners. “Zooca has a strong foundation in marine science and ingredient innovation. I look forward to helping strengthen the scientific basis for Zooca Calanus Oil and translating research into relevant applications and clear communication,” said Lisa Hemmingsen.
“Lisa brings strong scientific competence and experience from applied research and cross-disciplinary collaboration. Her appointment strengthens our ability to build robust documentation around Zooca Calanus Oil and support the continued development of our human health platform,” said Marianne Mæhlum, Chief Marketing and Innovation Officer.
Regions
ABOUT Zooca® Calanus® Oil
Zooca® Calanus® Oil is derived from Calanus finmarchicus, a zooplankton sustainably harvested in the Norwegian sea. The oil is unrefined, preserving its full spectrum of over 40 naturally occurring fatty acids, including the essential omega-3s EPA, DHA, and SDA. It also contains marine policosanols and astaxanthin—a unique combination of bioactive compounds clinically studied to support metabolic health, body composition, heart health and glucose management. This broad and balanced nutritional profile sets Zooca® Calanus® Oil apart as a novel, next-generation marine oil, going beyond traditional omega-3 supplements.
ABOUT ZOOCA®
Zooca® (Calanus AS) is a Norwegian bio-marine company that develops, produces, and commercializes unique functional health and nutrition products based on the sustainable utilization of the marine zooplankton Calanus finmarchicus, one of the largest renewable marine resources globally.
The company operates in both Norwegian and international markets and collaborates globally with industrial and scientific partners. Zooca® is the only company in Norway engaged in the industrial utilization of zooplankton.
Zooca® has carried out extensive research and development activities within harvesting technology, process and application development, product development, and scientific documentation for commercialization.
The main product, Zooca® Calanus® Oil, is used as a high-quality nutritional ingredient for human health. In animal health, the portfolio includes Zooca® Hydrolysate, Zooca® Powder, Zooca® AstaLipids, Zooca® NutriPods, and Zooca® SeaFrozen, which are used as functional ingredients in aquaculture, pet nutrition, and other applications across several markets.
